Open Innovation

GlaxoSmithKline is to establish an ‘Open Lab’ with $8 million funding to carry out research into neglected tropical diseases.

The US pharma company Eli Lilly has launched a new model of open innovation devised to get over the drug industry’s productivity problems.

An OECD conference highlights the hottest trend in corporate R&D. But take heed: in business or politics, beware too much success, says Richard L. Hudson.